Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 StudyEvan S. Dellon, Siddhesh Kamat, Elizabeth Laws et al.|Journal of Allergy and Clinical Immunology|2021Cited by 13